John Waller

600 total citations
38 papers, 415 citations indexed

About

John Waller is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, John Waller has authored 38 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Genetics. Recurrent topics in John Waller's work include Advanced Breast Cancer Therapies (6 papers), Inflammatory Bowel Disease (6 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). John Waller is often cited by papers focused on Advanced Breast Cancer Therapies (6 papers), Inflammatory Bowel Disease (6 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). John Waller collaborates with scholars based in United Kingdom, United States and Switzerland. John Waller's co-authors include Gavin Taylor‐Stokes, Sumesh Kachroo, James Piercy, E Sullivan, Christopher M. Black, Debanjali Mitra, Gary Milligan, Shrividya Iyer, Göran Toss and Margareta Möller and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

John Waller

34 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Waller United Kingdom 10 115 107 102 94 77 38 415
Saling Huang United States 10 32 0.3× 134 1.3× 187 1.8× 107 1.1× 66 0.9× 14 580
Didier Mayeur France 12 27 0.2× 209 2.0× 120 1.2× 24 0.3× 26 0.3× 50 390
Carrie Ye Canada 10 47 0.4× 251 2.3× 56 0.5× 47 0.5× 12 0.2× 45 393
Sabarish Ayyappan United States 10 161 1.4× 167 1.6× 48 0.5× 42 0.4× 111 1.4× 44 417
Sumati Rao United States 13 11 0.1× 316 3.0× 163 1.6× 93 1.0× 31 0.4× 42 566
Kejal Parikh United States 10 113 1.0× 298 2.8× 31 0.3× 23 0.2× 446 5.8× 40 634
José Villagra United States 5 231 2.0× 63 0.6× 58 0.6× 26 0.3× 233 3.0× 6 501
Johan Dalén United States 14 15 0.1× 57 0.5× 39 0.4× 121 1.3× 72 0.9× 29 534
Kashyap Patel United States 10 18 0.2× 56 0.5× 33 0.3× 119 1.3× 25 0.3× 34 288
M. Hensel Germany 10 253 2.2× 216 2.0× 35 0.3× 110 1.2× 241 3.1× 25 564

Countries citing papers authored by John Waller

Since Specialization
Citations

This map shows the geographic impact of John Waller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Waller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Waller more than expected).

Fields of papers citing papers by John Waller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Waller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Waller. The network helps show where John Waller may publish in the future.

Co-authorship network of co-authors of John Waller

This figure shows the co-authorship network connecting the top 25 collaborators of John Waller. A scholar is included among the top collaborators of John Waller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Waller. John Waller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McHugh, Michael J., et al.. (2025). Don't Get Salty, Baby! A Rare Case of Geller Syndrome. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A5717–A5717.
2.
Ay, Cihan, Maria Elisa Mancuso, Davide Matino, et al.. (2024). Noninterventional study assessing joint health in persons with hemophilia A after switching to turoctocog alfa pegol: design of pathfinderReal. Research and Practice in Thrombosis and Haemostasis. 8(2). 102363–102363. 1 indexed citations
3.
Waller, John, et al.. (2023). HTRS2023.P2.19 Treatment burden and unmet needs in hemophilia patients with inhibitors: results from a real-world observational study in the United States. Research and Practice in Thrombosis and Haemostasis. 7. 100241–100241. 1 indexed citations
4.
Eichler, Hermann, et al.. (2023). Real-World Experience of People with Hemophilia A Receiving Turoctocog Alfa Pegol (N8-GP): Results from a Patient Experience Survey. Patient Preference and Adherence. Volume 17. 3001–3014.
5.
Denee, Tom, John Waller, Tom Bailey, et al.. (2020). A retrospective chart review study to quantify the monthly medical resource use and costs of treating patients with treatment resistant depression in the United Kingdom. Current Medical Research and Opinion. 37(2). 311–319. 6 indexed citations
6.
Dignaß, Axel, John Waller, Joseph C. Cappelleri, et al.. (2019). Living with ulcerative colitis in Germany: a retrospective analysis of dose escalation, concomitant treatment use and healthcare costs. Journal of Medical Economics. 23(4). 415–427. 12 indexed citations
7.
Ward, Douglas, Moti Ramgopal, David J. Riedel, et al.. (2019). 2485. Real-world Experience with Dolutegravir Plus Rilpivirine Two-Drug Regimen. Open Forum Infectious Diseases. 6(Supplement_2). S861–S861. 1 indexed citations
8.
Fife, Daniel, John Waller, Sigal Kaplan, et al.. (2019). Awareness of, and Compliance with, Domperidone Revised Labeling After a Risk-Minimization Activity in Europe. Clinical Drug Investigation. 39(11). 1057–1066. 4 indexed citations
10.
Mitra, Debanjali, et al.. (2018). Real world treatment patterns associated with palbociclib combination therapy in Germany: Results from the IRIS study. Annals of Oncology. 29. viii110–viii110. 2 indexed citations
11.
Sebastian, Shaji, Jenna Roberts, John Waller, et al.. (2018). PRO2 Based Remote Monitoring in Ulcerative Colitis: A Prospective Real World Study. Value in Health. 21. S258–S258. 1 indexed citations
13.
Kruse, Caroline, Shirley Watson, Nichola Cooper, et al.. (2018). Patients with Immune Thrombocytopenia (ITP) Frequently Experience Severe Fatigue but Is It Under-Recognized By Physicians: Results from the ITP World Impact Survey (I-WISh). Blood. 132(Supplement 1). 2273–2273. 9 indexed citations
14.
Sullivan, E, James Piercy, John Waller, Christopher M. Black, & Sumesh Kachroo. (2017). Assessing gastroenterologist and patient acceptance of biosimilars in ulcerative colitis and Crohn's disease across Germany. PLoS ONE. 12(4). e0175826–e0175826. 39 indexed citations
15.
Harrison, Claire, Steffen Koschmieder, Lynda Foltz, et al.. (2017). The impact of myeloproliferative neoplasms (MPNs) on patient quality of life and productivity: results from the international MPN Landmark survey. Annals of Hematology. 96(10). 1653–1665. 80 indexed citations
16.
Lee, Andrew, James Pike, Michael Edwards, et al.. (2017). Quantifying the Benefits of Dimethyl Fumarate Over β Interferon and Glatiramer Acetate Therapies on Work Productivity Outcomes in MS Patients. Neurology and Therapy. 6(1). 79–90. 13 indexed citations
18.
Timpka, Toomas, et al.. (2007). Prevalence and Correlates of Insufficient Calcium Intake in a Swedish Population. Public Health Nursing. 24(6). 511–517. 5 indexed citations
19.
Waller, John, Olle Eriksson, Mats Foldevi, et al.. (2002). Knowledge of Osteoporosis in a Swedish Municipality—A Prospective Study. Preventive Medicine. 34(4). 485–491. 38 indexed citations
20.
Waller, John, Laşse Larsson, Owe Löfman, et al.. (1997). Logics and Logistics of Community Intervention Against Osteoporosis: An Evidence Basis. Journal of Medical Systems. 21(1). 33–47. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026